Image Trademark with Serial Number 86045285
Status: 710 - Cancelled - Section 8
Serial Number
86045285
Registration Number
4729961
Word Mark
Status
710 - Cancelled - Section 8
Status Date
2021-11-19
Filing Date
2013-08-22
Registration Number
4729961
Registration Date
2015-05-05
Mark Drawing
2000 - Illustration: Drawing or design without any word(s)/letter(s)/ number(s)
Typeset
Design Searches
011102, 021102 - Partial moons, including half moons and crescent moons. Eyes.
Published for Opposition Date
2015-02-17
Attorney Name
Law Office Assigned Location Code
M60
Employee Name
SPARER, ZACHARY R
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Description of Mark
The mark consists of one smaller crescent shape inside of a larger crescent shape.
Goods and Services
Pharmaceutical and veterinary preparations for the treatment and prophylaxis of infections by a bacterial, viral or fungal agent in skin infections, infections of major organs, ear, nose and throat infections, respiratory infections, subcutaneous infections, blood infections, cerebral infections and sexually transmitted infections, neurological and psychological disorders, nervous system diseases and disorders, migraines, headaches, coughs, colds, allergies and respiratory diseases, gastro-intestinal disorders, circulatory disorders, dermatological conditions, organ damage, cell proliferation, blood disorders, pain, cancers, women's health issues in the nature of medical conditions relating to reproduction disorders, conception disorders, pregnancy and contraception disorders, menstrual disorders, post-menopausal disorders, sexual function disorders, female hormone disorders, osteoporosis and breast cancer, uterine and ovarian cancer, men's health issues in the nature of reproduction disorders, conception disorders, contraception disorders, prostate disorders, testes disorders, male hormone disorders, alopecia, sexual function disorders, prostate cancer, testicular cancer and impotence, endocrinology disorders, pediatrics issues in the nature of mental health disorders, diabetes and endocrinology disorders, gastroenterology disorders, herpetology disorders, immunology disorders, skin infections, and allergies, nephology disorders, neurodisability disorders, neurology disorders, oncology disorders, respiratory disorders, rheumatology disorders, dermatology disorders, cardiology disorders, geriatrics issues in the nature of clinical, preventative, remedial and social aspects of illness in the elderly in the nature of immobility disorders, incontinence disorders, mental health disorders, strokes, heart disease, infectious diseases, diabetes, delirium, syncope, cerebral aging and Parkinsonism, and inflammation disorders; Sanitary preparations for medical purposes; Dietetic food and substances for medical or veterinary use in the nature of pasta, breads, cereals, crackers, meat, fruit, vegetables, confectionery, lipids in the nature of margarine, butter substitute, lard, fish oil, butter, peanut oil, soya bean oil, sunflower oil, sesame oil, coconut oil, olive oil, animal-derived fats and oils, plant-derived oils and dairy products in the nature of cheese, milk, butter, yoghurt, cream, and curds, all adapted for medical use; dietary supplements for humans and animals; chemical reagents for medical or veterinary purposes; chemical medical reagents for therapeutic and diagnostic purposes; chemico-pharmaceutical preparations for the treatment and prophylaxis of infections by a bacterial, viral or fungal agent in skin infections, infections of major organs, ear, nose and throat infections, respiratory infections, subcutaneous infections, blood infections, cerebral infections and sexually transmitted infections, neurological and psychological disorders, nervous system diseases and disorders, migraines, headaches, coughs, colds, allergies and respiratory diseases, gastro-intestinal disorders, circulatory disorders, dermatological conditions, organ damage, cell proliferation, blood disorders, pain, cancers, women's health issues in the nature of medical conditions relating to reproduction disorders, conception disorders, pregnancy and contraception disorders, menstrual disorders, post-menopausal disorders, sexual function disorders, female hormone disorders, osteoporosis and breast cancer, uterine and ovarian cancer, men's health issues in the nature of reproduction disorders, conception disorders, contraception disorders, prostate disorders, testes disorders, male hormone disorders, alopecia, sexual function disorders, prostate cancer, testicular cancer and impotence, endocrinology disorders, pediatrics issues in the nature of mental health disorders, diabetes and endocrinology disorders, gastroenterology disorders, herpetology disorders, immunology disorders, skin infections, and allergies, nephology disorders, neurodisability disorders, neurology disorders, oncology disorders, respiratory disorders, rheumatology disorders, dermatology disorders, cardiology disorders, geriatrics issues in the nature of clinical, preventative, remedial and social aspects of illness in the elderly in the nature of immobility disorders, incontinence disorders, mental health disorders, strokes, heart disease, infectious diseases, diabetes, delirium, syncope, cerebral aging and Parkinsonism, and inflammation disorders; medical chemical preparations for the treatment and prophylaxis of infections by a bacterial, viral or fungal agent in skin infections, infections of major organs, ear, nose and throat infections, respiratory infections, subcutaneous infections, blood infections, cerebral infections and sexually transmitted infections, neurological and psychological disorders, nervous system diseases and disorders, migraines, headaches, coughs, colds, allergies and respiratory diseases, gastro-intestinal disorders, circulatory disorders, dermatological conditions, organ damage, cell proliferation, blood disorders, pain, cancers, women's health issues in the nature of medical conditions relating to reproduction disorders, conception disorders, pregnancy and contraception disorders, menstrual disorders, post-menopausal disorders, sexual function disorders, female hormone disorders, osteoporosis and breast cancer, uterine and ovarian cancer, men's health issues in the nature of reproduction disorders, conception disorders, contraception disorders, prostate disorders, testes disorders, male hormone disorders, alopecia, sexual function disorders, prostate cancer, testicular cancer and impotence, endocrinology disorders, pediatrics issues in the nature of mental health disorders, diabetes and endocrinology disorders, gastroenterology disorders, herpetology disorders, immunology disorders, skin infections, and allergies, nephology disorders, neurodisability disorders, neurology disorders, oncology disorders, respiratory disorders, rheumatology disorders, dermatology disorders, cardiology disorders, geriatrics issues in the nature of clinical, preventative, remedial and social aspects of illness in the elderly in the nature of immobility disorders, incontinence disorders, mental health disorders, strokes, heart disease, infectious diseases, diabetes, delirium, syncope, cerebral aging and Parkinsonism, and inflammation disorders; medicines for the treatment and prophylaxis of infections by a bacterial, viral or fungal agent in skin infections, infections of major organs, ear, nose and throat infections, respiratory infections, subcutaneous infections, blood infections, cerebral infections and sexually transmitted infections, neurological and psychological disorders, nervous system diseases and disorders, migraines, headaches, coughs, colds, allergies and respiratory diseases, gastro-intestinal disorders, circulatory disorders, dermatological conditions, organ damage, cell proliferation, blood disorders, pain, cancers, women's health issues in the nature of medical conditions relating to reproduction disorders, conception disorders, pregnancy and contraception disorders, menstrual disorders, post-menopausal disorders, sexual function disorders, female hormone disorders, osteoporosis and breast cancer, uterine and ovarian cancer, men's health issues in the nature of reproduction disorders, conception disorders, contraception disorders, prostate disorders, testes disorders, male hormone disorders, alopecia, sexual function disorders, prostate cancer, testicular cancer and impotence, endocrinology disorders, pediatrics issues in the nature of mental health disorders, diabetes and endocrinology disorders, gastroenterology disorders, herpetology disorders, immunology disorders, skin infections, and allergies, nephology disorders, neurodisability disorders, neurology disorders, oncology disorders, respiratory disorders, rheumatology disorders, dermatology disorders, cardiology disorders, geriatrics issues in the nature of clinical, preventative, remedial and social aspects of illness in the elderly in the nature of immobility disorders, incontinence disorders, mental health disorders, strokes, heart disease, infectious diseases, diabetes, delirium, syncope, cerebral aging and Parkinsonism, and inflammation disorders
Goods and Services
Scientific and technological services, namely, pharmaceutical product evaluation, development and testing services; industrial analysis and research services in the nature of pharmaceutical product evaluation, development and testing services; biotechnology research; chemical research; research consulting in the field of pharmaceutical product evaluation, development and testing services; scientific, medical and clinical research and development in the nature of pharmaceutical product evaluation, development and testing services; research and development in the nature of pharmaceutical product evaluation, development and testing services; laboratory research services relating to pharmaceuticals; pharmaceutical research; medical and scientific laboratory services; laboratory testing services in the field of pharmaceutical product evaluation, development and testing services; testing of pharmaceuticals; chemical analysis; technological research in the nature of pharmaceutical product evaluation, development and testing services; conducting product evaluations in the field of new pharmaceuticals; inspection of pharmaceuticals; pharmaceutical product evaluation; pharmaceutical drug development services; information, advisory and consultancy services relating to all the aforesaid services
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
2 - Sec. 8 - Entire Registration
Class Status Date
2021-11-19
Primary Code
005
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
2 - Sec. 8 - Entire Registration
Class Status Date
2021-11-19
Primary Code
042
Correspondences
Name
Joan K. Archer
Address
Please log in with your Justia account to see this address.
Foreign Application Information
Filing Date | Application Number | Country | Foreign Priority Claim In |
2013-07-02 | 011948866 | EM | True |
2013-07-02 | 011948866 | EM | False |
False |
Trademark Events
Event Date | Event Description |
2013-08-26 | NEW APPLICATION ENTERED IN TRAM |
2013-08-30 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2013-08-31 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
2013-10-01 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
2013-10-01 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
2013-10-28 | ASSIGNED TO EXAMINER |
2013-10-28 | NON-FINAL ACTION WRITTEN |
2013-10-28 | NON-FINAL ACTION E-MAILED |
2013-10-28 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2014-04-08 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2014-04-08 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2014-04-25 | ASSIGNED TO LIE |
2014-05-06 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2014-05-06 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2014-05-08 | NON-FINAL ACTION WRITTEN |
2014-05-08 | NON-FINAL ACTION E-MAILED |
2014-05-08 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2014-11-07 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2014-11-07 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2014-11-07 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2014-11-08 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2014-11-26 | EXAMINERS AMENDMENT -WRITTEN |
2014-11-26 | EXAMINERS AMENDMENT E-MAILED |
2014-11-26 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
2014-11-26 | EXAMINER'S AMENDMENT ENTERED |
2014-12-01 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2014-12-04 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
2014-12-16 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
2015-01-02 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
2015-01-08 | NON-FINAL ACTION WRITTEN |
2015-01-08 | NON-FINAL ACTION E-MAILED |
2015-01-08 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2015-01-12 | EXAMINERS AMENDMENT -WRITTEN |
2015-01-12 | EXAMINERS AMENDMENT E-MAILED |
2015-01-12 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
2015-01-12 | EXAMINER'S AMENDMENT ENTERED |
2015-01-12 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2015-01-12 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
2015-01-28 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2015-02-17 | PUBLISHED FOR OPPOSITION |
2015-02-17 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2015-05-05 | REGISTERED-PRINCIPAL REGISTER |
2020-05-05 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
2021-11-19 | CANCELLED SEC. 8 (6-YR) |